contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


zealand-pharma-to-participate-in-the-2024-cantor-global-healthcare-conference-on-september-18th

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.

Zealand Pharma

Press Release – No. 9 / 2024 Zealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18th Copenhagen, Denmark, September 13, 2024 – Zealand Pharma A/S (CVR...

Press Release – No. 9 / 2024 Zealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18th Copenhagen, Denmark,&nbsp;September 13, 2024&nbsp;–&nbsp;Zealand Pharma A/S (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that Chief Medical Officer, David Kendall, MD, will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference at 9:10 a.m. ET (3:10 p.m. CET) on Wednesday, September 18, 2024. A live audio webcast of the fireside chat will be available at <a href="https://www.globenewswire.com/Tracker?data=9aq0oRsuUBJbxsQE5lU7GSxtxORCqMbIUF4xuLCYcBy49nk6y2knftO9_oF9Hi1_wo25W-uL3tNwB35BuHl50hkLWnHG8cKWv4TE_o9Nf-s_i4MYqtP838w2A1xm2BpXt2AqpQj5plLKipHJFMYTDDEl1FZGXaAlh8XBy5qq6Bc=">https://wsw.com/webcast/cantor22/zeal/2081412</a> and accessible through the company’s website at <a href="https://www.globenewswire.com/Tracker?data=9aq0oRsuUBJbxsQE5lU7GXeE3uTO4vxFgf-2WPkfAUXN-JIYmPSbdyx0tdcChpqviaOl_zdZsm905re9TD2AmPbmTLOkvQPTCDDCZKf0rF9bmVdzORxbB-O00daXPMOPJqomjhRMd4a5R8W6SfPgSAwNLYvd-3hbDz_I-xWTJUw=">https://www.zealandpharma.com/investors/events-presentations/</a> where a recording of the webcast will also be archived after the event. About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand’s business and activities, please visit <a href="https://www.globenewswire.com/Tracker?data=X0DMsBVEPGODEl0JS2uvcoq1B3EsJhH8vtJI4bX2oZTQuZrcwe5AUcDzstV56NCgqdNnS4cPZ4VFYbioHOsTDN5u0jPDkFi_dhwyyLEFDVM=">www.zealandpharma.com</a>. Contacts: <table style="border-collapse: collapse; border-collapse:collapse ;"><tbody><tr><td style="width:12cm;;vertical-align: top ;"> Adam Lange (Investors) </td></tr><tr><td style="width:12cm;;vertical-align: top ;"> Investor Relations Officer </td></tr><tr><td style="width:12cm;;vertical-align: top ;"> Zealand Pharma </td></tr><tr><td style="width:12cm;;vertical-align: top ;"> alange@zealandpharma.com </td></tr><tr><td style="width:12cm;;vertical-align: top ;"> &nbsp; </td></tr><tr><td style="width:12cm;;vertical-align: top ;"> Anna Krassowska, PhD (Investors and Media) </td></tr><tr><td style="width:12cm;;vertical-align: top ;"> Vice President, Investor Relations &amp; Corporate Communications </td></tr><tr><td style="width:12cm;;vertical-align: top ;"> Zealand Pharma </td></tr><tr><td style="width:12cm;;vertical-align: top ;"> akrassowska@zealandpharma.com </td></tr></tbody></table><img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMDk5MTczMyM0MDE5NDQyMjUjMjAwMTcwMQ=="> <img src="https://ml-eu.globenewswire.com/media/ZmU5MjQyNGEtZjA5Zi00NjBlLTg3NTgtNjU0ZjRhMmZmNTU3LTEwMTMyNzQ=/tiny/Zealand-Pharma.png">

Zealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18th

Stay up to date with our newsletter